Industry

Organization Successfully Closes $13.5M “Unlock Potential” Capital Campaign Ribbon-Cutting Ceremony Marks Major Milestone and Honors Partnership with the Golden Valley Community GOLDEN VALLEY, Minn.–(BUSINESS WIRE)–Franklin Center, Minnesota’s only comprehensive education and services center for those on the autism spectrum or with other neurodiversities, celebrates its new campus and new name with a ribbon-cutting ceremony on … [Read more…]

Announces second-quarter fiscal 2023 earnings release date IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE: MCK) today announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027. “We are pleased to continue our long-standing relationship … [Read more…]

TTHX1114 has the potential to be the first pharmacologic treatment for corneal endothelial dystrophies CHICAGO–(BUSINESS WIRE)–Trefoil Therapeutics, a clinical-stage biotechnology company focused on restoring sight to people with corneal diseases, today announced positive Phase 2 results for TTHX1114 in patients with Fuchs Endothelial Corneal Dystrophy (FECD). TTHX1114, a proprietary engineered fibroblast growth factor-1 (FGF1) variant, … [Read more…]

ALAMEDA, Calif.–(BUSINESS WIRE)–#CRISPR–Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, today announced it will participate in two upcoming investor conferences: Scribe co-founder and CEO Benjamin Oakes will participate in a panel titled “Gene Editing: Next-Generation Technologies Worth Watching,” at 9:30 a.m. ET on Oct. 3, 2022, at … [Read more…]

Sitagliptin is an active ingredient in JANUVIA®, JANUMET® and JANUMET® XR RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Court of Appeals for the Federal Circuit ruled in favor of the company in a patent challenge brought by Mylan Pharmaceuticals, Inc. (now … [Read more…]

Latest ‘Back on the Books’ survey suggests lack of knowledge may keep women from receiving lifesaving health care ALEXANDRIA, Va.–(BUSINESS WIRE)–A new survey by the Prevent Cancer Foundation® reveals an alarming statistic: almost half (49%) of American women 40 and older report they have not had a breast cancer screening in more than two years. … [Read more…]

VieCure Inc., a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announces further facility investments and employee expansion in the Denver Tech Center DENVER–(BUSINESS WIRE)–VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced today the opening of the Dr. Don Iverson … [Read more…]

Largest study to-date of corneal cross-linking to treat keratoconus Company aims to develop leading standard of care for keratoconus and corneal ectasia SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase 2 study for keratoconus in Cornea: The Journal of Cornea and … [Read more…]

Agilent will fund STEM students from underrepresented groups, and provide lab instrumentation and mentorship to support postgraduate research in the life sciences SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) is launching a partnership with Delaware State University (DSU), a leading historically Black university, to increase the share of underrepresented students entering STEM fields, a … [Read more…]

First-of-its-kind system enables a new class of solid-state thermal management systems that is currently only possible with bulkier, mechanical alternatives PASADENA, Calif.–(BUSINESS WIRE)–DTP Thermoelectrics has been awarded a patent that opens the door for solid-state deep cooling thermal management. The patent is based on theoretical and analytical models that have been validated through the fabrication … [Read more…]